Effect of tetrabenazine use on restless legs syndrome

Sleep Medicine

Volumn 11, Issue 9, 2010, Pages 958-959

  Ondo, William G ^a   Jia, Judy J ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE RECEPTOR STIMULATING AGENT; GABAPENTIN; IRON; LEVODOPA; METHADONE; NARCOTIC AGENT; ROPINIROLE; TETRABENAZINE;

CHOREA; DISEASE CLASSIFICATION; DRUG EFFICACY; DRUG MEGADOSE; DRUG WITHDRAWAL; DYSTONIA; GILLES DE LA TOURETTE SYNDROME; HUMAN; HYPERKINESIA; LETTER; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RESTLESS LEGS SYNDROME; STEREOTYPY; TARDIVE DYSKINESIA; THERAPY EFFECT; TREATMENT DURATION; UNSPECIFIED SIDE EFFECT;

ADRENERGIC UPTAKE INHIBITORS; HUMANS; HYPERKINESIS; RESTLESS LEGS SYNDROME; RETROSPECTIVE STUDIES; TETRABENAZINE;

EID: 84755160681     PISSN: 13899457     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.sleep.2010.05.009     Document Type: Letter

References (8)

1. Allen R.P., Picchietti D., Hening W.A., Trenkwalder C., Walters A.S., Montplaisi J. Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med 2003, 4(2):101-119.
2. Satija P., Ondo W.G. Restless legs syndrome: pathophysiology, diagnosis and treatment. CNS Drugs 2008, 22(6):497-518.
3. Connor J.R., Boyer P.J., Menzies S.L., et al. Neuropathological examination suggests impaired brain iron acquisition in restless legs syndrome. Neurology 2003, 61(3):304-309.
4. Poceta J.S., Parsons L., Engelland S., Kripke D.F. Circadian rhythm of CSF monoamines and hypocretin-1 in restless legs syndrome and Parkinson's disease. Sleep Med 2009, 10(1):129-133.
5. Allen R.P., Connor J.R., Hyland K., Earley C.J. Abnormally increased CSF 3-Ortho-methyldopa (3-OMD) in untreated restless legs syndrome (RLS) patients indicates more severe disease and possibly abnormally increased dopamine synthesis. Sleep Med 2009, 10(1):123-128.
6. Connor J.R., Wang X.S., Allen R.P., et al. Altered dopaminergic profile in the putamen and substantia nigra in restless leg syndrome. Brain 2009, 132(Pt 9):2403-2412.
7. Garcia-Borreguero D., Allen R.P., Kohnen R., et al. Diagnostic standards for dopaminergic augmentation of restless legs syndrome: report from a World Association of Sleep Medicine - International Restless Legs Syndrome Study Group consensus conference at the Max Planck Institute. Sleep Med 2007, 8(5):520-530.
8. Zhao H., Zhu W., Pan T., et al. Spinal cord dopamine receptor expression and function in mice with 6-OHDA lesion of the A11 nucleus and dietary iron deprivation. J Neurosci Res 2007, 85(5):1065-1076.